5,7,12,13-Tetraoxo-5,7,12,13-tetrahydrodinaphtho[2,3-b:2',3'-d]thiophen-2-ylbutylcarbamate

ID: ALA4476574

PubChem CID: 155538151

Max Phase: Preclinical

Molecular Formula: C25H17NO6S

Molecular Weight: 459.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCNC(=O)Oc1ccc2c(=O)c3sc4c(=O)c5ccccc5c(=O)c4c3c(=O)c2c1

Standard InChI:  InChI=1S/C25H17NO6S/c1-2-3-10-26-25(31)32-12-8-9-15-16(11-12)20(28)18-17-19(27)13-6-4-5-7-14(13)21(29)23(17)33-24(18)22(15)30/h4-9,11H,2-3,10H2,1H3,(H,26,31)

Standard InChI Key:  OLJQKFKCUGKGIW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   15.3737  -10.5625    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.7650   -9.2981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0253  -10.0716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8208  -10.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3002   -8.6851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7058  -10.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9493   -9.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4030   -8.7216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9159  -10.2715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1015   -8.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3608   -9.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1565   -9.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6937   -9.1684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4296   -8.3957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6345   -8.2399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3666   -9.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6123   -8.8989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0671   -8.3022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2762   -8.4762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0334   -9.2523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5802   -9.8457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6475   -7.9418    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6720  -11.0515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0815  -11.0065    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0385   -7.9110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9669   -7.7800    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7688   -7.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3061   -7.3218    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0334   -8.7107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1080   -7.4793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6453   -6.8636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4472   -7.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9845   -6.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  1  1  0
  1  3  1  0
  2  7  1  0
  2  3  2  0
  2  5  1  0
  3  4  1  0
  4 11  1  0
 10  5  1  0
  6  7  2  0
  6  9  1  0
  7  8  1  0
  8 17  1  0
 16  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  8 22  2  0
  9 23  2  0
  4 24  2  0
  5 25  2  0
 14 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476574

    ---

Associated Targets(Human)

SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Malme-3M (44254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Calf thymus DNA (4845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.48Molecular Weight (Monoisotopic): 459.0777AlogP: 3.57#Rotatable Bonds: 4
Polar Surface Area: 106.61Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -0.24

References

1. Hammons JC, Trzoss L, Jimenez PC, Hirata AS, Costa-Lotufo LV, La Clair JJ, Fenical W..  (2019)  Advance of Seriniquinone Analogues as Melanoma Agents.,  10  (2): [PMID:30783501] [10.1021/acsmedchemlett.8b00391]

Source